Loading asset research
Cardio Diagnostics Holdings Inc. Common stock
CDIONasdaq · USD · StocksQuote as of · Exchange session not verified$2.03
+2.53%
Today
CDIO
Loading 1D prices…
Market cap
$6M
Volume
25.2K
52w high
$7.9152w low
$0.97Company profile
Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Sector
Health Care
Industry
In Vitro & In Vivo Diagnostic Substances
Exchange
Nasdaq
Display currency
USD
Location
Chicago, IL, United States
Employees
15
Fiscal year end
1231
CIK
1870144
Session & valuation
Open$2.05
Previous close$1.98
Day high$2.09
Day low$1.98
30-day avg. volume45.6K
Outstanding shares3M
Diluted EPS-$3.71
Latest annual period
P/E (trailing)-0.55
P/E (forward)-8.12
Price / book0.81
Beta2.23
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2835
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| VNRXVolitionRX Limited Common Stock | $5.9M | $1.7M | -1352.16% | -$4.40 | -8.15% | Buy |
| TRIBTrinity Biotech plc American Depositary Shares | $6.3M | $43.8M | -85.36% | -$53.10 | -0.64% | Unrated |
| BMRABiomerica Inc. Common Stock | $10.3M | $4.5M | -84.77% | -$1.30 | +0.45% | Unrated |
| QCLSQ/C Technologies Inc. Common Stock | $14M | $0.00 | — | -$8.66 | +4.24% | Unrated |
| VRAXVirax Biolabs Group Limited Ordinary Shares | $2.1M | $12.4K | -40439.10% | -$12.64 | -0.35% | Buy |